Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their ... Nasdaq Auryxia is currently approved to treat elevated serum phosphorus levels in the estimated 450,000 people in the U.S. who have End Stage Renal Disease (ESRD) and require dialysis treatment. The majority of ESRD patients require chronic treatment with ... and more »

...